• Corpus ID: 20744728

Cannabis-Induced Psychosis: A Review

  title={Cannabis-Induced Psychosis: A Review},
  author={Ruby S. Grewal and Tony P. George and Frcpc},
Numerous lines of evidence suggest a correlation between cannabis consumption and a variety of psychiatric conditions, including cannabis-induced psychosis. 
3 Citations

Emergent Medical Illnesses Related to Cannabis Use.

Among the many untoward effects being seen, illnesses that will be discussed are: cannabinoid associated hyperemesis, acute psychosis, cannabinoid catatonia syndrome, acute myo-pericarditis and ingestions.

COMT Val158Met moderation of cannabis‐induced psychosis: a momentary assessment study of ‘switching on’ hallucinations in the flow of daily life

A functional polymorphism in the catechol‐o‐methyltransferase gene (COMT Val158Met) may moderate the psychosis‐inducing effects of cannabis, and dynamic effects in the flow of daily life are extended.

Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases

Cannabis-induced psychotic disorders are of great clinical and prognostic importance, and development of schizophrenia-spectrum disorders was often delayed, and 47.1% of patients received a diagnosis more a year after seeking treatment for a cannabis-induced psychosis.

Carbamazepine as an adjunct in the treatment of schizophrenia-like psychosis related to cannabis abuse.

The efficacy of an adjuvant application of carbamazepine in cannabis-related schizophrenia-like psychosis not responsive to neuroleptic treatment is reported for the first time. In two patients,

Motivational Intervention to Reduce Cannabis Use in Young People with Psychosis: A Randomized Controlled Trial

MI is well accepted by patients suffering from psychosis and has a short-term impact on cannabis use when added to standard care, but the differential effect was not maintained at 1-year follow-up.

Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication.

DIPT may be a more important predictor of negative symptoms at outcome than is delay in starting antipsychotic medication alone, and Delay in intensive psychosocial treatment may also be related to outcome.

Substance Abuse and Mental Health Services Administration

  • Bethany Figg
  • Psychology, Medicine
    Journal of Consumer Health on the Internet
  • 2018
The goal is to provide information about research and services available on substance use and mental disorders to advance the behavioral health of the nation, and reduce the impact of substance abuse and mental illness on America's communities.

Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities.

The present crude estimates should guide and help prioritize public health-oriented interventions for the cannabis-related health burden in the population in Canada and formal burden of disease calculations should be conducted.